We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.15 | -1.62% | 9.10 | 8.70 | 9.50 | 9.25 | 9.10 | 9.25 | 321,812 | 14:04:44 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.05 | 84.43M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/10/2018 14:09 | So the BOD have been caught with their pants down again, there has obviously been a problem for a while and they have now been forced to own up with the AGM being only a few days away. Holloway has reiterated several times that everything is on track and everything is going to plan with the trial starting this year. There was a time when having DR as a title stood for integrity and honesty well we know that between Goodfellow, Holloway and Chiplin not an ounce of integrity exists just a willingness to fleece Investors at every opportunity. Evans left in 2015 due to his failure to deliver to Shareholders it's a shame none of the others have the same integrity just too busy lining their own pockets. Can't wait to see what positive spin these numpties come up with at the AGM. | panama7 | |
24/10/2018 14:06 | Agema/Tosh, the company is called nanoco, he can't even spell his own name! Came across this (purely by chance, wasn't looking) from almost exactly 3 years ago: Inanaco, 27th October 2015: Quote............ Read what you will into the results .. happy to stick with No risk as the science or the engine of the program cannot be faulted, so will win over providing Scancell can fund it, and they seem to feel they can. Which begs the question of just how many to hold for a pension scheme .. so here is Inanacos Prediction .. 2020 Scancell if its kept together and not sold will exceed £4b market cap and rising, and at any time between now and 2017 mega deals could be signed which would speed up the "jump". ..............unquot | gazza | |
24/10/2018 13:56 | Tosh. He did the same thing with a share called nanaco. He even named himself after it. It was going to be the next big thing in quantum for tv. It bombed, he went missing from the bb. De ja vu.? | agema | |
24/10/2018 13:43 | KonarA, good luck with getting the idiot to admit anything, let alone apologise. He has been in this position of being shown to be 100% wrong many times before, but even in the face of overwhelming evidence to the contrary, he will undoubtedly try to wriggle out of it, by attempting to change everyone's words, and taking the topic to something totally different... it doesn't work by the way, but thats exactly what he will try to do, mark my words. He's not clever enough though. | tosh123 | |
24/10/2018 13:20 | Gazza. Lol. If the ip, patents, company was worth $100 million as you believe. Do you not think for one minute the company would not be swallowed up by now, when the mkt cap is around £38 million.? I think the big boys have it right, and a few on here are cuckoo. Never fall in love with a share, it will cost you a fortune. | agema | |
24/10/2018 13:15 | I'm pretty sure it was RG who indicated he wanted to split... ATB | oldnotwise | |
24/10/2018 13:06 | ONW, wasn't it the other way round ? DE wanted to split it and sell one arm, whereas RG didnt ? I honestly cant remember now. | tosh123 | |
24/10/2018 12:51 | Tosh well, we've had it from the horse's mouth (RG) that he wanted to split the company after Moditope Discovery (2012) and DE didn't.. Whether that has anything to do with it is anyone's guess. ATB | oldnotwise | |
24/10/2018 12:49 | I see that the " gang " are up to their old tricks again by getting any posts that dont fit their agenda, removed. Really is so pathetic. | tosh123 | |
24/10/2018 12:24 | I really wish that our former director David Evans could be in a position that he could spill the beans as to what actually happened , and what triggered his leaving the company. I have been told by someone quite close, that there was a distinct difference of opinion between DE and RG, and it was that disagreement that culminated in DE resigning. | tosh123 | |
24/10/2018 11:58 | agema, the IP and patents have to be worth $100M to a big pharma. After all, it's petty cash to them. | gazza | |
24/10/2018 11:55 | What.?????! Why would anyone pay 20p a share when the share price is 9p.? Why would anyone buy now. When they have turned it down repeatedly for the last 7 years.? Why would anyone buy this company, when it currently has nothing in trials and repeatedly announce delays.? What do delays equals.? More costs and hence a cashcall quicker than anyone thinks or plans for. I would rate the chance of Scancell getting bought this year at 0 per cent. Have a good afternoon all. | agema | |
24/10/2018 11:43 | losing patient lives as well as patent life. Sad. Have to agree with Panama. This has the hallmark of a take over, lock stock and barrel. LD will get a job as senior scientist, the rest will get P45s. PIs lucky to get 20p per share. | gazza | |
24/10/2018 11:42 | More delays. More costs. More uncertainty. Not certain the FDA will even sanction the trial to go ahead. Ouch. | agema | |
24/10/2018 11:23 | I think I'd have hired a good lawyer and walked. There's no guarantee they'll ever get FDA approval. Meanwhile a promising drug is being kept out of trials and losing patent life, all paid for by Scancell shareholders. | supernumerary | |
24/10/2018 10:54 | Wanderer, i can't argue with that too much either, but he was duped by a village idiot. Anyway, enough said about the uneducated, lets just hope that the BOD get something over the line, and that they do it soon, otherwise there will be blood on the street. | tosh123 | |
24/10/2018 10:52 | Morning all even though it is a very bad one. Agree totally about incompetence of BOD and more delays. Hate to be proved right again but the good people on this board have called it right again. The sad Failed Professor Plum has gone quiet and no wonder as he has taken another pounding over his over hyped and over tryhped predictions of No risk,All in and £8 a share-blathering idiot and I will tell fine F2😍F at AGM if he has guts to turn up. This is a disarster as my mate Craig on Cekebrity Come Dancing says and baNANA will fail on Brexit as well.He is a total saddo. No one will listen to his trHYPE again and he has cost a lot of good people serious money so he is preying on worst kind of manipulation and CON. What makes it worse is he is happy to interfere in Val board and C97 and post their thoughts in there and help destro the value there. They are all trying to make the world a better place but all these BODs seem to be is selfish arrogant promise everything and deliver nothing jobsworths and I will have no truck with them or likes of baBABA as they are out and out liars and CONmen | drdobson1 | |
24/10/2018 10:28 | I really do not like that Ichor device or the terms that Scancell have signed up to. There are better solutions out there, but alas, they are stuck with it for SCIB1. Fortunately they have opted to look at alternatives for SCIB2 I will have to miss the AGM next Tuesday, but will attend the Proactive meeting on Thursday November 1st, so Ichor will definitely be featuring in the Q&As. | timbo003 | |
24/10/2018 10:05 | Tosh, quite frankly a fire sale is hopefully the best option, I stated ages ago the best thing that could happen to this share is that they cannot get any funds and are forced to sell . Let's face it this BOD are incapable of realising any value for shareholders their record proves that. the best solution is a total buy out with Lindy given a role on the buyers BOD or given a consultancy role. | panama7 | |
24/10/2018 09:59 | Tosh, I am no fan of Inane but he isn't the problem and if people have bought shares based on his idiotic posts more fool them. The BOD are solely responsible for yet more lies, only a few weeks ago Glencross tweeted that he had spoken to Holloway and was reassured that everything was on track for the trial to commence this year. We have heard Holloway state everything on track several times when obviously he has blatantly lied and lied even to their largest shareholders. We now know why KCB resigned , she was obviously aghast at the astronomical pay rises been dished out over the last few years when the BOD have done everything in their power to decimate the share price so that they can pick up ever cheaper shares and options. I have stated for ages that they have lied to and misled Investors ever since Goodfellow's Frankfurt video. There is a whole litany of lies and untruths , they are quite simply an absolute disgrace and the share price performance is a very accurate reflection of their performance and their lies. We have been told for 6 years there is significant interest in both platforms by large Pharma, yet not one single deal has been forthcoming and if there was significant interest then there is no way funds would have been raised at the discounted levels we have had to endure , it is a total contradiction and yet proof of more lies. Can't wait for the AGM and the BOD to justify their performance , their salaries and in particular Goodfellow's 100k pay rise in the year he steps down. Quite simply a BOD and individuals who are nothing short of a disgrace. | panama7 | |
24/10/2018 09:58 | Wanderer, bang on, which is no doubt why the proactive presentation was arranged so quickly, the BOD would have known about the FDA problems some weeks ago, and therefore have to present some kind of positive spin on matters, and do it soon. The main issue with this though is , if they do need to raise more cash, i honestly doubt whether there will be any real appetite from the long suffering II's, which then leaves a large percentage of the money to be raised by the PI's. Bearing in mind the performance over the last 7 - 8 years, i doubt whether there will be too much interest from the PI's either, which then creates the perfect storm, and a fire sale will be the only option. Therefore, TF's comments about the current scenario not affecting the risk profile of the company is naive in the extreme, of course it increases the risks, the trial has been delayed due to the FDA not being sufficiently comfortable with the make up, thats not good news, ITS BAD, and the share price reflects that fact. Something has to give. | tosh123 | |
24/10/2018 09:43 | Hmm so more delays Scib 1 now put back to H1 2019, only with FDA approval, which will imo.drift out until 2020, CRUK imo.will not release any monies until this trial as met all FDA approvals. Which brings the inevitable cash call @5-6p which will dilute long term share holders out of existence | wanderer1210_0 | |
24/10/2018 09:25 | Profit master, they will be busily trying to work out how to butter the RNS up, how to put a positive spin on it, and justify why the rest of the investing world is wrong, and they are right. Mark my words, once the dust has settled, they will be back with a bucket load of manure for their faithful followers to swallow.... again ! | tosh123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions